ECSP024406A - Composicion de vacuna multivalente - Google Patents

Composicion de vacuna multivalente

Info

Publication number
ECSP024406A
ECSP024406A EC2002004406A ECSP024406A ECSP024406A EC SP024406 A ECSP024406 A EC SP024406A EC 2002004406 A EC2002004406 A EC 2002004406A EC SP024406 A ECSP024406 A EC SP024406A EC SP024406 A ECSP024406 A EC SP024406A
Authority
EC
Ecuador
Prior art keywords
hepatitis
virus
vaccine composition
multivalent vaccine
haemophilus influenzae
Prior art date
Application number
EC2002004406A
Other languages
English (en)
Inventor
Dominique Boutriau
Jan Poolman
Pierre Michel Desmons
Carine Capiau
Dominique Lemoine
Original Assignee
Glaxo Smithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Smithkline Biologicals Sa filed Critical Glaxo Smithkline Biologicals Sa
Publication of ECSP024406A publication Critical patent/ECSP024406A/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

El invento se refiere a vacunas de combinación que pueden prevenir ante Bordetella pertussis, Clostridium tetani, Corynebacterium diphteriae, y opcionalmente, el virus de la hepatitis B y/o Haemophilus influenzae de tipo b. Sin embargo, la fabricación y el empleo de vacunas multivalentes más ambiciosas son todavía un desafío. La administración de dichas vacunas multivalentes puede prevenir o tratar la infección por Bordetella pertussis, Clostridium tetani, Corynebacterium diphteriae, virus de la hepatitis B, Haemophilus influenzae y N meningitidis y preferiblemente también el virus de la hepatitis A y/o el virus de la polio, en las que los componentes de la vacuna no interfieren significativamente con la actividad inmunológica de cualquiera de los componentes de la vacuna.
EC2002004406A 2000-06-29 2002-12-27 Composicion de vacuna multivalente ECSP024406A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015999.6A GB0015999D0 (en) 2000-06-29 2000-06-29 Novel compounds

Publications (1)

Publication Number Publication Date
ECSP024406A true ECSP024406A (es) 2003-04-25

Family

ID=9894692

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2002004406A ECSP024406A (es) 2000-06-29 2002-12-27 Composicion de vacuna multivalente

Country Status (3)

Country Link
EC (1) ECSP024406A (es)
GB (1) GB0015999D0 (es)
ZA (1) ZA200300755B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2461350T3 (es) * 2003-01-30 2014-05-19 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos

Also Published As

Publication number Publication date
ZA200300755B (en) 2004-04-28
GB0015999D0 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
PE20020126A1 (es) Composicion de vacuna
DK2097102T3 (da) Kombinationsvaccine med reducerede mængder af poliovirusantigen
NO20015073L (no) Vaksiner
DK0914153T3 (da) Multivalente DTP-poliovacciner
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
BR0208595A (pt) kit de vacina, composição imunogênica multivalente, uso desta, método de imunização de um hospedeiro humano contra doença causada por bordetella pertussis, clostridium tetani, corynebacterium diphtheriae, vìrus da hepatite b, poliovìrus e n. meningitidis, processo para produzir a composição imunogênica multivalente, e, método para imunizar um hospedeiro humano contra doença causada pelos haemophilus influenzae e streptococcus pneumoniae
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
ATE125568T1 (de) Analoge der untereinheit des von rekombinanter dns abgeleiteten bordetella-toxins.
LU91596I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique,d'antoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine, de virus poliomyélitique inactivé type 1, type 2 et type 3 et de polyoside capsulaire d'haemophilus influenzae type b (Infanrix - IPV/Hib)
HUP9904287A1 (hu) Acelluláris pertussis vakcina diftéria- és tetanusz-toxoidokkal
PE20211648A1 (es) Composicion de vacuna combinada que comprende dosis reducidas del virus inactivado de la polio y metodo de preparacion de la misma
EA200700496A1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
ECSP024406A (es) Composicion de vacuna multivalente
BRPI0411815A (pt) vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
MX2019001780A (es) Composicion de vacuna multivalente novedosa.
AR117191A1 (es) Composiciones inmunogénicas
DK0603386T3 (da) Parenteral immunisering mod rotavirus
UA95810C2 (uk) Інактивована поліовірусна вакцина
RU2002130182A (ru) Способ вакцинопрофилактики полиомиелита на крайнем севере
GB9611501D0 (en) Vaccine compositions
RU2003101497A (ru) Способ профилактики акдс-вакциной на крайнем севере
RU99110617A (ru) Способ сезонной вакцинопрофилактики полиомиелита на крайнем севере
AR097217A1 (es) Composiciones inmunógenas de combinación